These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 22906294)
1. 18F-fluorodeoxyglucose positron emission tomography/computed tomography findings in mucosa-associated lymphoid tissue lymphoma of the larynx: a case report and literature review. Zhao K; Luo YZ; Zhou SH; Dai BL; Luo XM; Yan SX; Wang QY; Ling L J Int Med Res; 2012; 40(3):1192-206. PubMed ID: 22906294 [TBL] [Abstract][Full Text] [Related]
2. 18F-FDG PET/CT for staging and response assessment of primary parotid MALT lymphoma with multiple sites involvement: A case report. Ren Y; Huang L; Han Y; Cui Z; Li J; Dong C; Liu J Medicine (Baltimore); 2019 Feb; 98(5):e14270. PubMed ID: 30702589 [TBL] [Abstract][Full Text] [Related]
3. Mucosa-associated lymphoid tissue lymphoma with unusual Zhang NS; Shi F; Kong L; Zhu H World J Gastroenterol; 2017 Jan; 23(3):551-559. PubMed ID: 28210093 [TBL] [Abstract][Full Text] [Related]
4. Persistence of primary MALT lymphoma of the urinary bladder after rituximab with CHOP chemotherapy and radiotherapy. Bacalja J; Ulamec M; Rako D; Bošković L; Trnski D; Vrdoljak E; Krušlin B In Vivo; 2013; 27(4):545-9. PubMed ID: 23812229 [TBL] [Abstract][Full Text] [Related]
5. [Primary Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma with Large Cell Transformation of the Prostate : A Case Report]. Kinjo T; Yamanaka Y; Katayama K; Minato N; Mori N; Yoshioka T; Onishi M; Sugahara H; Fujita S Hinyokika Kiyo; 2015 Jul; 61(7):293-8. PubMed ID: 26278216 [TBL] [Abstract][Full Text] [Related]
6. F-18 FDG PET/CT evaluation of radiotherapy response in rare case of mucosa-associated lymphoid tissue lymphoma. Minamimoto R; Tateishi U; Tomita N; Inayama Y; Omura-Minamisawa M; Tayama Y; Hata M; Kubota Y; Inoue T Ann Nucl Med; 2010 Feb; 24(2):115-9. PubMed ID: 20077163 [TBL] [Abstract][Full Text] [Related]
7. Primary radiation therapy in patients with localized orbital marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT Lymphoma). Son SH; Choi BO; Kim GW; Yang SW; Hong YS; Choi IB; Kim YS Int J Radiat Oncol Biol Phys; 2010 May; 77(1):86-91. PubMed ID: 19632068 [TBL] [Abstract][Full Text] [Related]
8. Primary laryngeal lymphoma: case report. Word R; Urquhart AC; Ejercito VS Ear Nose Throat J; 2006 Feb; 85(2):109-11. PubMed ID: 16579200 [TBL] [Abstract][Full Text] [Related]
10. Detection rate of fluorine-18-fluorodeoxyglucose positron emission tomography in patients with marginal zone lymphoma of MALT type: a meta-analysis. Treglia G; Zucca E; Sadeghi R; Cavalli F; Giovanella L; Ceriani L Hematol Oncol; 2015 Sep; 33(3):113-24. PubMed ID: 25047160 [TBL] [Abstract][Full Text] [Related]
11. [Clinical characteristics and diagnosis of pulmonary mucosa-associated lymphoid tissue-derived (MALT) lymphoma: a retrospective analysis of 29 cases]. Li AW; Xu JF; Zhou CC; Wu CY; Wang YL Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):390-3. PubMed ID: 22883464 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of interim PET/CT response for the treatment of advanced-stage marginal zone lymphoma in the post-rituximab era. Song GY; Yoon SE; Kim SJ; Kim JS; Koh Y; Moon JH; Oh SY; Lee HS; Shin HJ; Do YR; Lee WS; Kim DS; Park Y; Yhim HY; Yang DH Sci Rep; 2020 Jul; 10(1):11649. PubMed ID: 32669642 [TBL] [Abstract][Full Text] [Related]
13. Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET. Halasz LM; Jacene HA; Catalano PJ; Van den Abbeele AD; Lacasce A; Mauch PM; Ng AK Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e647-54. PubMed ID: 22607911 [TBL] [Abstract][Full Text] [Related]
14. Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era. Avivi I; Zilberlicht A; Dann EJ; Leiba R; Faibish T; Rowe JM; Bar-Shalom R Am J Hematol; 2013 May; 88(5):400-5. PubMed ID: 23423884 [TBL] [Abstract][Full Text] [Related]
15. Role of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in evaluating breast mucosa-associated lymphoid tissue lymphoma: A case series. Albano D; Bosio G; Orlando E; Bertagna F Hematol Oncol; 2017 Dec; 35(4):884-889. PubMed ID: 28004400 [TBL] [Abstract][Full Text] [Related]
16. [Extranodal non-Hodgkin's lymphoma of MALT-type stage I. A case report]. Kuhnt T; Wollschläger B; Bloching M; Krause U; Dunst J Strahlenther Onkol; 2003 Jun; 179(6):396-400. PubMed ID: 12789466 [TBL] [Abstract][Full Text] [Related]
17. Activity of rituximab plus cyclophosphamide, doxorubicin/mitoxantrone, vincristine and prednisone in patients with relapsed MALT lymphoma. Raderer M; Wohrer S; Streubel B; Drach J; Jager U; Turetschek K; Troch M; Puspok A; Zielinski CC; Chott A Oncology; 2006; 70(6):411-7. PubMed ID: 17220639 [TBL] [Abstract][Full Text] [Related]
18. Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07). Mamot C; Klingbiel D; Hitz F; Renner C; Pabst T; Driessen C; Mey U; Pless M; Bargetzi M; Krasniqi F; Gigli F; Hany T; Samarin A; Biaggi C; Rusterholz C; Dirnhofer S; Zucca E; Martinelli G J Clin Oncol; 2015 Aug; 33(23):2523-9. PubMed ID: 26150440 [TBL] [Abstract][Full Text] [Related]
19. Whole-body positron emission tomography/computed tomography imaging and staging of orbital lymphoma. Roe RH; Finger PT; Kurli M; Tena LB; Iacob CE Ophthalmology; 2006 Oct; 113(10):1854-8. PubMed ID: 16860867 [TBL] [Abstract][Full Text] [Related]